Relmada Therapeutics, Inc.
Hedge Funds Holdings
Last updated:
Relmada Therapeutics, Inc.‘s stocks are currently a part of 52 hedge funds’ portfolios, which represents 28.4% of the total amount of its stocks outstanding. This makes up a total of 8.06M shares of Relmada Therapeutics, Inc.. Compared to the previous quarter, the number fell by -57.93% or -11.10M shares fewer. As for the holding position changes, 34.62% (18) of current hedge fund investors increased the number of shares held, 38.46% (20) of current holders sold a part of the shares held, and 32.69% (17) closed the holdings completely. 4 hedge funds are new holders of Relmada Therapeutics, Inc. stock in Q1 2023, it is 7.69% of total holders.
Hedge funds holding Relmada Therapeutics (Q2 2016 – Q1 2023)
| Q2 2016 | 1 |
|---|---|
| Q3 2016 | 0 |
| Q4 2019 | 44 |
| Q1 2020 | 42 |
| Q2 2020 | 73 |
| Q3 2020 | 71 |
| Q4 2020 | 78 |
| Q1 2021 | 80 |
| Q2 2021 | 82 |
| Q3 2021 | 83 |
| Q4 2021 | 93 |
| Q1 2022 | 111 |
| Q2 2022 | 108 |
| Q3 2022 | 131 |
| Q4 2022 | 107 |
| Q1 2023 | 52 |
Hedge funds changes in Relmada Therapeutics positions (Q2 2016 – Q1 2023)
| Q2 2016 | 1 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q3 2016 | 0 | 0 | 0 | 1 | -1 |
| Q4 2019 | 44 | 0 | 0 | 0 | 0 |
| Q1 2020 | 11 | 18 | 7 | 9 | -3 |
| Q2 2020 | 39 | 20 | 7 | 8 | -1 |
| Q3 2020 | 11 | 22 | 19 | 13 | 6 |
| Q4 2020 | 13 | 26 | 24 | 6 | 9 |
| Q1 2021 | 12 | 19 | 26 | 9 | 14 |
| Q2 2021 | 8 | 32 | 20 | 6 | 16 |
| Q3 2021 | 14 | 36 | 12 | 13 | 8 |
| Q4 2021 | 25 | 27 | 24 | 13 | 4 |
| Q1 2022 | 31 | 40 | 21 | 13 | 6 |
| Q2 2022 | 14 | 50 | 24 | 14 | 6 |
| Q3 2022 | 35 | 46 | 32 | 13 | 5 |
| Q4 2022 | 37 | 28 | 34 | 59 | -51 |
| Q1 2023 | 4 | 18 | 20 | 17 | -7 |
Hedge funds changes in Relmada Therapeutics stock options (Q2 2016 – Q1 2023)
| Q2 2016 | 0 | 0 |
|---|---|---|
| Q3 2016 | 0 | 0 |
| Q4 2019 | 2,130,000 | 5,000 |
| Q1 2020 | 880,000 | 3,000 |
| Q2 2020 | 11,153,000 | 513,000 |
| Q3 2020 | 7,953,000 | 11,000 |
| Q4 2020 | 6,723,000 | 17,000 |
| Q1 2021 | 16,997,000 | 1,151,000 |
| Q2 2021 | 13,411,000 | 5,651,000 |
| Q3 2021 | 5,546,000 | 785,000 |
| Q4 2021 | 4,184,000 | 1,592,000 |
| Q1 2022 | 26,379,000 | 13,362,000 |
| Q2 2022 | 29,063,000 | 25,159,000 |
| Q3 2022 | 116,703,000 | 198,238,000 |
| Q4 2022 | 7,393,701 | 1,673,776 |
| Q1 2023 | 45,892,000 | 14,693,000 |